Dementia Research Group Publications

  1. Engedal K, Benth JŠ, Wagle J, Gjøra L, Selbæk G, Persson K (2024)
    Normative Scores on the Clock Drawing Test Among Older Adults from a Large Population Survey in Norway: The HUNT Study
    J Alzheimers Dis, 101 (1), 223-234
    DOI 10.3233/JAD-231331, PubMed 39213081
  2. Knapskog AB, Edwin TH, Ueland PM, Ulvik A, Fang EF, Eldholm RS, Halaas NB, Giil LM, Saltvedt I, Watne LO, Aksnes M (2024)
    Sex-specific associations of kynurenic acid with neopterin in Alzheimer's disease
    Alzheimers Res Ther, 16 (1), 167
    DOI 10.1186/s13195-024-01531-7, PubMed 39068471
  3. Amland R, Selbæk G, Brækhus A, Edwin TH, Engedal K, Knapskog AB, Olsrud ER, Persson K (2024)
    Clinically feasible automated MRI volumetry of the brain as a prognostic marker in subjective and mild cognitive impairment
    Front Neurol, 15, 1425502
    DOI 10.3389/fneur.2024.1425502, PubMed 39011362
  4. Aksnes M, Schibstad MH, Chaudhry FA, Neerland BE, Caplan G, Saltvedt I, Eldholm RS, Myrstad M, Edwin TH, Persson K, Idland AV, Pollmann CT, Olsen RB, Wyller TB, Zetterberg H, Cunningham E, Watne LO (2024)
    Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium
    Commun Med (Lond), 4 (1), 124
    DOI 10.1038/s43856-024-00558-z, PubMed 38937571
  5. Leonardsen EH, Persson K, Grødem E, Dinsdale N, Schellhorn T, Roe JM, Vidal-Piñeiro D, Sørensen Ø, Kaufmann T, Westman E, Marquand A, Selbæk G, Andreassen OA, Wolfers T, Westlye LT, Wang Y (2024)
    Constructing personalized characterizations of structural brain aberrations in patients with dementia using explainable artificial intelligence
    NPJ Digit Med, 7 (1), 110
    DOI 10.1038/s41746-024-01123-7, PubMed 38698139
  6. Edwin TH, Håberg AK, Zotcheva E, Bratsberg B, Jugessur A, Engdahl B, Bowen C, Selbæk G, Kohler HP, Harris JR, Tom SE, Krokstad S, Mekonnen T, Stern Y, Skirbekk VF, Strand BH (2024)
    Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and Dementia in Later Life: The HUNT4 70+ Study
    Neurology, 102 (9), e209353
    DOI 10.1212/WNL.0000000000209353, PubMed 38630959
  7. Persson K, Barca ML, Edwin TH, Cavallin-Eklund L, Tangen GG, Rhodius-Meester HFM, Selbæk G, Knapskog AB, Engedal K (2024)
    Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia
    Brain Behav, 14 (2), e3397
    DOI 10.1002/brb3.3397, PubMed 38600026
  8. Sandvig HV, Aam S, Alme KN, Lydersen S, Magne Ueland P, Ulvik A, Wethal T, Saltvedt I, Knapskog AB (2024)
    Neopterin, kynurenine metabolites, and indexes related to vitamin B6 are associated with post-stroke cognitive impairment: The Nor-COAST study
    Brain Behav Immun, 118, 167-177
    DOI 10.1016/j.bbi.2024.02.030, PubMed 38428649
  9. Zotcheva E, Bratsberg B, Strand BH, Jugessur A, Engdahl BL, Bowen C, Selbæk G, Kohler HP, Harris JR, Weiss J, Tom SE, Krokstad S, Mekonnen T, Edwin TH, Stern Y, Håberg AK, Skirbekk V (2023)
    Trajectories of occupational physical activity and risk of later-life mild cognitive impairment and dementia: the HUNT4 70+ study
    Lancet Reg Health Eur, 34, 100721
    DOI 10.1016/j.lanepe.2023.100721, PubMed 37927437
  10. Persson K, Leonardsen EH, Edwin TH, Knapskog AB, Tangen GG, Selbæk G, Wolfers T, Westlye LT, Engedal K (2023)
    Diagnostic accuracy of brain age prediction in a memory clinic population and comparison with clinically available volumetric measures
    Sci Rep, 13 (1), 14957
    DOI 10.1038/s41598-023-42354-0, PubMed 37696909
  11. Boen R, Kaufmann T, van der Meer D, Frei O, Agartz I, Ames D, Andersson M, Armstrong NJ, Artiges E, Atkins JR, Bauer J, Benedetti F, Boomsma DI, Brodaty H, Brosch K, Buckner RL, Cairns MJ, Calhoun V, Caspers S, Cichon S, Corvin AP, Crespo-Facorro B, Dannlowski U, David FS, de Geus EJC et al. (2023)
    Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers
    Biol Psychiatry, 95 (2), 147-160
    DOI 10.1016/j.biopsych.2023.08.018, PubMed 37661008
  12. Aksnes M, Capogna E, Vidal-Piñeiro D, Chaudhry FA, Myrstad M, Idland AV, Halaas NB, Dakhil S, Blennow K, Zetterberg H, Walhovd KB, Watne LO, Fjell AM (2023)
    Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals
    Neurobiol Aging, 131, 11-23
    DOI 10.1016/j.neurobiolaging.2023.05.012, PubMed 37549446
  13. Chwiszczuk LJ, Breitve MH, Kirsebom BB, Selnes P, Fløvig JC, Knapskog AB, Skogseth RE, Hubbers J, Holst-Larsen E, Rongve A (2023)
    The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
    Front Aging Neurosci, 15, 1163184
    DOI 10.3389/fnagi.2023.1163184, PubMed 37304077
  14. Knapskog AB, Aksnes M, Edwin TH, Ueland PM, Ulvik A, Fang EF, Eldholm RS, Halaas NB, Saltvedt I, Giil LM, Watne LO (2023)
    Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease
    Alzheimers Dement, 19 (12), 5573-5582
    DOI 10.1002/alz.13162, PubMed 37264981
  15. Aksnes M, Edwin TH, Saltvedt I, Eldholm RS, Chaudhry FA, Halaas NB, Myrstad M, Watne LO, Knapskog AB (2023)
    Sex-specific associations of matrix metalloproteinases in Alzheimer's disease
    Biol Sex Differ, 14 (1), 35
    DOI 10.1186/s13293-023-00514-x, PubMed 37221606
  16. Sandvig HV, Aam S, Alme KN, Askim T, Beyer MK, Ellekjær H, Ihle-Hansen H, Lydersen S, Mollnes TE, Munthe-Kaas R, Næss H, Saltvedt I, Seljeseth YM, Thingstad P, Wethal T, Knapskog AB (2023)
    Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study
    Stroke, 54 (5), 1303-1311
    DOI 10.1161/STROKEAHA.122.041965, PubMed 37026459
  17. Tangen GG, Sverdrup K, Taraldsen K, Persson K, Engedal K, Bekkhus-Wetterberg P, Knapskog AB (2023)
    Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
    Front Aging Neurosci, 15, 1101306
    DOI 10.3389/fnagi.2023.1101306, PubMed 36820757
  18. Medbøen IT, Persson K, Nåvik M, Totland TH, Bergh S, Treviño CS, Ulstein I, Engedal K, Knapskog AB, Brækhus A, Øksengård AR, Horndalsveen PO, Saltvedt I, Lyngroth AL, Ranhoff AH, Skrettingland DB, Naik M, Soares JZ, Johnsen B, Selbaek G (2022)
    Cohort profile: the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) - a national research and quality registry with a biomaterial collection
    BMJ Open, 12 (9), e058810
    DOI 10.1136/bmjopen-2021-058810, PubMed 36448543
  19. Watne LO, Pollmann CT, Neerland BE, Quist-Paulsen E, Halaas NB, Idland AV, Hassel B, Henjum K, Knapskog AB, Frihagen F, Raeder J, Godø A, Ueland PM, McCann A, Figved W, Selbæk G, Zetterberg H, Fang EF, Myrstad M, Giil LM (2023)
    Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients
    J Clin Invest, 133 (2)
    DOI 10.1172/JCI163472, PubMed 36409557
  20. Wagle J, Selbæk G, Benth JŠ, Gjøra L, Rønqvist TK, Bekkhus-Wetterberg P, Persson K, Engedal K (2023)
    The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study
    J Alzheimers Dis, 91 (1), 321-343
    DOI 10.3233/JAD-220672, PubMed 36404547
  21. Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, Zettergren A, Mishra A, Ali M, Andrade V, Bellenguez C, Kleineidam L, Küçükali F, Sung YJ, Tesí N, Vromen EM, Wightman DP, Alcolea D, Alegret M, Alvarez I, Amouyel P, Athanasiu L, Bahrami S, Bailly H, Belbin O et al. (2022)
    Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
    Acta Neuropathol, 144 (5), 821-842
    DOI 10.1007/s00401-022-02454-z, PubMed 36066633
  22. Barca ML, Alnæs D, Engedal K, Persson K, Eldholm RS, Siafarikas N, Selseth Almdahl I, Stylianou-Korsnes M, Saltvedt I, Selbæk G, Westlye LT (2022)
    Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia
    Dement Geriatr Cogn Dis Extra, 12 (2), 107-114
    DOI 10.1159/000521114, PubMed 35950148
  23. Soares JZ, Valeur J, Šaltytė Benth J, Knapskog AB, Selbæk G, Bogdanovic N, Pettersen R (2022)
    Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study
    J Alzheimers Dis, 89 (3), 825-834
    DOI 10.3233/JAD-220407, PubMed 35938253
  24. Henjum K, Watne LO, Godang K, Halaas NB, Eldholm RS, Blennow K, Zetterberg H, Saltvedt I, Bollerslev J, Knapskog AB (2022)
    Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease
    Transl Psychiatry, 12 (1), 151
    DOI 10.1038/s41398-022-01901-5, PubMed 35397615
  25. Persson K, Edwin TH, Knapskog AB, Tangen GG, Selbæk G, Engedal K (2022)
    Hippocampal Atrophy Subtypes of Alzheimer's Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications
    Dement Geriatr Cogn Disord, 51 (1), 80-89
    DOI 10.1159/000522382, PubMed 35344967
  26. Aksnes M, Aass HCD, Tiiman A, Terenius L, Bogdanović N, Vukojević V, Knapskog AB (2022)
    Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
    J Alzheimers Dis, 86 (3), 1459-1470
    DOI 10.3233/JAD-215504, PubMed 35213378
  27. Soares JZ, Valeur J, Šaltytė Benth J, Knapskog AB, Selbæk G, Arefi G, Gilfillan GD, Tollisen A, Bogdanovic N, Pettersen R (2022)
    Vitamin D in Alzheimer's Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum
    J Alzheimers Dis, 86 (3), 1301-1314
    DOI 10.3233/JAD-215536, PubMed 35180126
  28. Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME (2022)
    Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
    Quant Imaging Med Surg, 12 (1), 493-509
    DOI 10.21037/qims-21-188, PubMed 34993096
  29. Alme KN, Ulvik A, Askim T, Assmus J, Mollnes TE, Naik M, Næss H, Saltvedt I, Ueland PM, Knapskog AB (2021)
    Neopterin and kynurenic acid as predictors of stroke recurrence and mortality: a multicentre prospective cohort study on biomarkers of inflammation measured three months after ischemic stroke
    BMC Neurol, 21 (1), 476
    DOI 10.1186/s12883-021-02498-w, PubMed 34879833
  30. Müller EG, Edwin TH, Strand BH, Stokke C, Revheim ME, Knapskog AB (2022)
    Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
    J Alzheimers Dis, 85 (1), 197-205
    DOI 10.3233/JAD-215046, PubMed 34776444
  31. Aam S, Gynnild MN, Munthe-Kaas R, Saltvedt I, Lydersen S, Knapskog AB, Ihle-Hansen H, Ellekjær H, Eldholm RS, Fure B (2021)
    The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study
    Front Neurol, 12, 678794
    DOI 10.3389/fneur.2021.678794, PubMed 34421786
  32. Siafarikas N, Alnæs D, Monereo-Sanchez J, Lund MJ, Selbaek G, Stylianou-Korsnes M, Persson K, Barca ML, Almdahl IS, Fladby T, Aarsland D, Andreassen OA, Westlye LT (2021)
    Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia
    Int Psychogeriatr, 33 (11), 1217-1228
    DOI 10.1017/S1041610221000934, PubMed 34399870
  33. Alme KN, Askim T, Assmus J, Mollnes TE, Naik M, Næss H, Saltvedt I, Ueland PM, Ulvik A, Knapskog AB (2021)
    Investigating novel biomarkers of immune activation and modulation in the context of sedentary behaviour: a multicentre prospective ischemic stroke cohort study
    BMC Neurol, 21 (1), 318
    DOI 10.1186/s12883-021-02343-0, PubMed 34399717
  34. Schellhorn T, Zucknick M, Askim T, Munthe-Kaas R, Ihle-Hansen H, Seljeseth YM, Knapskog AB, Næss H, Ellekjær H, Thingstad P, Wyller TB, Saltvedt I, Beyer MK (2021)
    Pre-stroke cognitive impairment is associated with vascular imaging pathology: a prospective observational study
    BMC Geriatr, 21 (1), 362
    DOI 10.1186/s12877-021-02327-2, PubMed 34126944
  35. Aksnes M, Aass HCD, Tiiman A, Edwin TH, Terenius L, Bogdanović N, Vukojević V, Knapskog AB (2021)
    Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
    Transl Neurodegener, 10 (1), 18
    DOI 10.1186/s40035-021-00244-3, PubMed 34099032
  36. Knapskog AB, Engedal K, Selbæk G, Øksengård AR (2021)
    [Alzheimer’s disease – diagnosis and treatment]
    Tidsskr Nor Laegeforen, 141 (7)
    DOI 10.4045/tidsskr.20.0919, PubMed 33950641
  37. Halaas NB, Zetterberg H, Idland AV, Knapskog AB, Watne LO, Blennow K (2021)
    Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium
    J Alzheimers Dis, 81 (2), 667-677
    DOI 10.3233/JAD-201341, PubMed 33814433
  38. Hernes SS, Flak MM, Løhaugen GCC, Skranes J, Hol HR, Madsen BO, Knapskog AB, Engvig A, Pripp A, Ulstein I, Lona T, Zhang X, Chang L (2021)
    Working Memory Training in Amnestic and Non-amnestic Patients With Mild Cognitive Impairment: Preliminary Findings From Genotype Variants on Training Effects
    Front Aging Neurosci, 13, 624253
    DOI 10.3389/fnagi.2021.624253, PubMed 33658917
  39. Einstad MS, Saltvedt I, Lydersen S, Ursin MH, Munthe-Kaas R, Ihle-Hansen H, Knapskog AB, Askim T, Beyer MK, Næss H, Seljeseth YM, Ellekjær H, Thingstad P (2021)
    Associations between post-stroke motor and cognitive function: a cross-sectional study
    BMC Geriatr, 21 (1), 103
    DOI 10.1186/s12877-021-02055-7, PubMed 33546620
  40. Aksnes M, Tiiman A, Edwin TH, Terenius L, Bogdanović N, Vukojević V, Knapskog AB (2021)
    Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
    Front Aging Neurosci, 12, 608628
    DOI 10.3389/fnagi.2020.608628, PubMed 33488383
  41. Edwin TH, Strand BH, Persson K, Engedal K, Selbaek G, Knapskog AB (2021)
    Neuropsychiatric symptoms and comorbidity: Associations with dementia progression rate in a memory clinic cohort
    Int J Geriatr Psychiatry, 36 (6), 960-969
    DOI 10.1002/gps.5500, PubMed 33462872
  42. Rokicki J, Wolfers T, Nordhøy W, Tesli N, Quintana DS, Alnaes D, Richard G, de Lange AG, Lund MJ, Norbom L, Agartz I, Melle I, Naerland T, Selbaek G, Persson K, Nordvik JE, Schwarz E, Andreassen OA, Kaufmann T, Westlye LT (2020)
    Multimodal imaging improves brain age prediction and reveals distinct abnormalities in patients with psychiatric and neurological disorders
    Hum Brain Mapp, 42 (6), 1714-1726
    DOI 10.1002/hbm.25323, PubMed 33340180
  43. Edwin TH, Henjum K, Nilsson LNG, Watne LO, Persson K, Eldholm RS, Saltvedt I, Halaas NB, Selbæk G, Engedal K, Strand BH, Knapskog AB (2020)
    A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
    Alzheimers Dement (Amst), 12 (1), e12128
    DOI 10.1002/dad2.12128, PubMed 33313376
  44. Mjørud M, Selbæk G, Bjertness E, Edwin TH, Engedal K, Knapskog AB, Strand BH (2020)
    Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis
    PLoS One, 15 (12), e0243513
    DOI 10.1371/journal.pone.0243513, PubMed 33275638
  45. Soares JZ, Pettersen R, Benth JŠ, Persson K, Strobel C, Selbæk G, Bogdanovic N (2021)
    Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms
    J Alzheimers Dis, 79 (1), 311-321
    DOI 10.3233/JAD-201018, PubMed 33252081
  46. Alme KN, Knapskog AB, Næss H, Naik M, Beyer M, Ellekjaer H, English C, Hansen HI, Kummeneje CS, Munthe-Kaas R, Saltvedt I, Seljeseth Y, Tan X, Thingstad P, Askim T (2020)
    Is long-bout sedentary behaviour associated with long-term glucose levels 3 months after acute ischaemic stroke? A prospective observational cohort study
    BMJ Open, 10 (11), e037475
    DOI 10.1136/bmjopen-2020-037475, PubMed 33243789
  47. Edwin TH, Strand BH, Persson K, Engedal K, Selbæk G, Knapskog AB (2020)
    Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis
    Int Psychogeriatr, 33 (8), 779-789
    DOI 10.1017/S1041610220003270, PubMed 33213607
  48. Knapskog AB, Henjum K, Idland AV, Eldholm RS, Persson K, Saltvedt I, Watne LO, Engedal K, Nilsson LNG (2020)
    Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification
    Sci Rep, 10 (1), 15886
    DOI 10.1038/s41598-020-72878-8, PubMed 32985583
  49. Aman Y, Ryan B, Torsetnes SB, Knapskog AB, Watne LO, McEwan WA, Fang EF (2020)
    Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases
    Int Rev Neurobiol, 155, 169-202
    DOI 10.1016/bs.irn.2020.02.008, PubMed 32854854
  50. Elvsåshagen T, Bahrami S, van der Meer D, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Beyer MK, Blasi G, Borgwardt S, Boye B, Buitelaar J, Bøen E, Celius EG, Cervenka S, Conzelmann A, Coynel D, Di Carlo P, Djurovic S, Eisenacher S, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B et al. (2020)
    The genetic architecture of human brainstem structures and their involvement in common brain disorders
    Nat Commun, 11 (1), 4016
    DOI 10.1038/s41467-020-17376-1, PubMed 32782260
  51. Aam S, Einstad MS, Munthe-Kaas R, Lydersen S, Ihle-Hansen H, Knapskog AB, Ellekjær H, Seljeseth Y, Saltvedt I (2020)
    Post-stroke Cognitive Impairment-Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study
    Front Neurol, 11, 699
    DOI 10.3389/fneur.2020.00699, PubMed 32765406
  52. Gynnild MN, Aakerøy R, Spigset O, Askim T, Beyer MK, Ihle-Hansen H, Munthe-Kaas R, Knapskog AB, Lydersen S, Naess H, Røsstad TG, Seljeseth YM, Thingstad P, Saltvedt I, Ellekjaer H (2020)
    Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke
    J Intern Med, 289 (3), 355-368
    DOI 10.1111/joim.13161, PubMed 32743852
  53. Aksnes M, Müller EG, Tiiman A, Edwin TH, Terenius L, Revheim ME, Vukojević V, Bogdanović N, Knapskog AB (2020)
    Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
    J Alzheimers Dis, 77 (2), 831-842
    DOI 10.3233/JAD-200237, PubMed 32741818
  54. Munthe-Kaas R, Aam S, Ihle-Hansen H, Lydersen S, Knapskog AB, Wyller TB, Fure B, Thingstad P, Askim T, Beyer MK, Næss H, Seljeseth YM, Ellekjær H, Pendlebury ST, Saltvedt I (2020)
    Impact of different methods defining post-stroke neurocognitive disorder: The Nor-COAST study
    Alzheimers Dement (N Y), 6 (1), e12000
    DOI 10.1002/trc2.12000, PubMed 32211505
  55. Sajjad MU, Blennow K, Knapskog AB, Idland AV, Chaudhry FA, Wyller TB, Zetterberg H, Watne LO (2020)
    Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients
    J Alzheimers Dis, 73 (4), 1363-1372
    DOI 10.3233/JAD-190941, PubMed 31929159
  56. Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Di Carlo P, Djurovic S, Dørum ES et al. (2020)
    Publisher Correction: Common brain disorders are associated with heritable patterns of apparent aging of the brain
    Nat Neurosci, 23 (2), 295
    DOI 10.1038/s41593-019-0553-6, PubMed 31848485
  57. Zugic Soares J, Pettersen R, Saltyte Benth J, Knapskog AB, Selbæk G, Bogdanovic N (2019)
    Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register
    J Nutr Health Aging, 23 (8), 725-731
    DOI 10.1007/s12603-019-1220-z, PubMed 31560030
  58. Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Di Carlo P, Djurovic S, Dørum ES et al. (2019)
    Common brain disorders are associated with heritable patterns of apparent aging of the brain
    Nat Neurosci, 22 (10), 1617-1623
    DOI 10.1038/s41593-019-0471-7, PubMed 31551603
  59. Leavey N, Hammond SP, Shepstone L, Cross J, Zetterberg H, Cunningham C, MacLullich A, Leiv Otto Watne, Minihane AM, Ballard C, Knapskog AB, Hall R, Howard G, Hammond M, Fox C (2019)
    Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients
    BMC Neurol, 19 (1), 223
    DOI 10.1186/s12883-019-1447-7, PubMed 31493787
  60. Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME (2019)
    Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
    PLoS One, 14 (8), e0221365
    DOI 10.1371/journal.pone.0221365, PubMed 31430334
  61. Hazen J, Vistnes M, Barca ML, Eldholm RS, Persson K, Brækhus A, Saltvedt I, Selbæk G, Engedal K, Knapskog AB (2020)
    The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia
    Alzheimer Dis Assoc Disord, 34 (1), 47-53
    DOI 10.1097/WAD.0000000000000342, PubMed 31414991
  62. Halse I, Bjørkløf GH, Engedal K, Rokstad AMM, Persson K, Eldholm RS, Selbaek G, Barca ML (2019)
    Applicability of the locus of control of behaviour scale for people with dementia
    Aging Ment Health, 24 (12), 2111-2116
    DOI 10.1080/13607863.2019.1652244, PubMed 31402698
  63. Strand BH, Knapskog AB, Persson K, Holt Edwin T, Bjertness E, Engedal K, Selbaek G (2019)
    The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway
    Dement Geriatr Cogn Disord, 47 (4-6), 355-365
    DOI 10.1159/000501269, PubMed 31319412
  64. Flak MM, Hol HR, Hernes SS, Chang L, Engvig A, Bjuland KJ, Pripp A, Madsen BO, Knapskog AB, Ulstein I, Lona T, Skranes J, Løhaugen GCC (2019)
    Adaptive Computerized Working Memory Training in Patients With Mild Cognitive Impairment. A Randomized Double-Blind Active Controlled Trial
    Front Psychol, 10, 807
    DOI 10.3389/fpsyg.2019.00807, PubMed 31031677
  65. Flak MM, Hol HR, Hernes SS, Chang L, Ernst T, Engvig A, Bjuland KJ, Madsen BO, Lindland EMS, Knapskog AB, Ulstein ID, Lona TEE, Skranes J, Løhaugen GCC (2019)
    Corrigendum: Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment
    Front Aging Neurosci, 11, 37
    DOI 10.3389/fnagi.2019.00037, PubMed 30863303
  66. Barca ML, Eldholm RS, Persson K, Bjørkløf GH, Borza T, Telenius E, Knapskog AB, Brækhus A, Saltvedt I, Selbæk G, Engedal K (2018)
    Cortisol levels among older people with and without depression and dementia
    Int Psychogeriatr, 31 (4), 597-601
    DOI 10.1017/S1041610218001199, PubMed 30556798
  67. Flak MM, Hol HR, Hernes SS, Chang L, Ernst T, Engvig A, Bjuland KJ, Madsen BO, Lindland EMS, Knapskog AB, Ulstein ID, Lona TEE, Skranes J, Løhaugen GCC (2018)
    Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment
    Front Aging Neurosci, 10, 384
    DOI 10.3389/fnagi.2018.00384, PubMed 30519185
  68. Thingstad P, Askim T, Beyer MK, Bråthen G, Ellekjær H, Ihle-Hansen H, Knapskog AB, Lydersen S, Munthe-Kaas R, Næss H, Pendlebury ST, Seljeseth YM, Saltvedt I (2018)
    The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study
    BMC Neurol, 18 (1), 193
    DOI 10.1186/s12883-018-1198-x, PubMed 30477436
  69. Strand BH, Knapskog AB, Persson K, Edwin TH, Amland R, Mjørud M, Bjertness E, Engedal K, Selbæk G (2018)
    Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
    PLoS One, 13 (9), e0204436
    DOI 10.1371/journal.pone.0204436, PubMed 30240425
  70. Knapskog AB, Braekhus A, Engedal K (2019)
    The Effect of Changing the Amyloid β42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway
    Alzheimer Dis Assoc Disord, 33 (1), 72-74
    DOI 10.1097/WAD.0000000000000268, PubMed 30106756
  71. Eldholm RS, Persson K, Barca ML, Knapskog AB, Cavallin L, Engedal K, Selbaek G, Skovlund E, Saltvedt I (2018)
    Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics
    BMC Geriatr, 18 (1), 120
    DOI 10.1186/s12877-018-0813-4, PubMed 29788900
  72. Eldholm RS, Barca ML, Persson K, Knapskog AB, Kersten H, Engedal K, Selbæk G, Brækhus A, Skovlund E, Saltvedt I (2018)
    Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics
    J Alzheimers Dis, 61 (3), 1221-1232
    DOI 10.3233/JAD-170436, PubMed 29254085
  73. Persson K, Barca ML, Cavallin L, Brækhus A, Knapskog AB, Selbæk G, Engedal K (2017)
    Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease
    Acta Radiol, 59 (8), 997-1001
    DOI 10.1177/0284185117743778, PubMed 29172642
  74. Persson K, Eldholm RS, Barca ML, Cavallin L, Ferreira D, Knapskog AB, Selbæk G, Brækhus A, Saltvedt I, Westman E, Engedal K (2017)
    MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis
    PLoS One, 12 (10), e0186595
    DOI 10.1371/journal.pone.0186595, PubMed 29036183
  75. Knapskog AB, Eldholm RS, Braekhus A, Engedal K, Saltvedt I (2017)
    Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
    BMC Geriatr, 17 (1), 210
    DOI 10.1186/s12877-017-0611-4, PubMed 28893185
  76. Barca ML, Persson K, Eldholm R, Benth JŠ, Kersten H, Knapskog AB, Saltvedt I, Selbaek G, Engedal K (2017)
    Trajectories of depressive symptoms and their relationship to the progression of dementia
    J Affect Disord, 222, 146-152
    DOI 10.1016/j.jad.2017.07.008, PubMed 28704802
  77. Doan NT, Engvig A, Zaske K, Persson K, Lund MJ, Kaufmann T, Cordova-Palomera A, Alnæs D, Moberget T, Brækhus A, Barca ML, Nordvik JE, Engedal K, Agartz I, Selbæk G, Andreassen OA, Westlye LT, Alzheimer's Disease Neuroimaging Initiative (2017)
    Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples
    Neuroimage, 158, 282-295
    DOI 10.1016/j.neuroimage.2017.06.070, PubMed 28666881
  78. Persson K, Barca ML, Eldholm RS, Cavallin L, Šaltytė Benth J, Selbæk G, Brækhus A, Saltvedt I, Engedal K (2017)
    Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease
    Dement Geriatr Cogn Disord, 44 (1-2), 12-24
    DOI 10.1159/000477342, PubMed 28614836
  79. Knapskog AB, Bogdanovic N (2017)
    [Not Available]
    Tidsskr Nor Laegeforen, 137 (10), 685
    DOI 10.4045/tidsskr.17.0388, PubMed 28551955
  80. Doan NT, Engvig A, Persson K, Alnæs D, Kaufmann T, Rokicki J, Córdova-Palomera A, Moberget T, Brækhus A, Barca ML, Engedal K, Andreassen OA, Selbæk G, Westlye LT (2017)
    Dissociable diffusion MRI patterns of white matter microstructure and connectivity in Alzheimer's disease spectrum
    Sci Rep, 7, 45131
    DOI 10.1038/srep45131, PubMed 28338052
  81. Córdova-Palomera A, Kaufmann T, Persson K, Alnæs D, Doan NT, Moberget T, Lund MJ, Barca ML, Engvig A, Brækhus A, Engedal K, Andreassen OA, Selbæk G, Westlye LT (2017)
    Disrupted global metastability and static and dynamic brain connectivity across individuals in the Alzheimer's disease continuum
    Sci Rep, 7, 40268
    DOI 10.1038/srep40268, PubMed 28074926
  82. Persson K, Selbæk G, Brækhus A, Beyer M, Barca M, Engedal K (2016)
    Fully automated structural MRI of the brain in clinical dementia workup
    Acta Radiol, 58 (6), 740-747
    DOI 10.1177/0284185116669874, PubMed 27687251
  83. Knapskog AB, Engedal K, Braekhus A (2016)
    Performance of Cerebrospinal Fluid Biomarkers of Alzheimer Disease in a Memory Clinic in Norway
    Alzheimer Dis Assoc Disord, 30 (1), 8-14
    DOI 10.1097/WAD.0000000000000126, PubMed 26629677
  84. Barca ML, Engedal K, Selbaek G, Knapskog AB, Laks J, Coutinho E, Benth JŠ (2015)
    Confirmatory factor analysis of the Cornell scale for depression in dementia among patient with dementia of various degrees
    J Affect Disord, 188, 173-8
    DOI 10.1016/j.jad.2015.08.062, PubMed 26363614
  85. Persson K, Brækhus A, Selbæk G, Kirkevold Ø, Engedal K (2015)
    Burden of Care and Patient's Neuropsychiatric Symptoms Influence Carer's Evaluation of Cognitive Impairment
    Dement Geriatr Cogn Disord, 40 (5-6), 256-67
    DOI 10.1159/000437298, PubMed 26304633
  86. Araujo NB, Moraes HS, Silveira H, Arcoverde C, Vasques PE, Barca ML, Knapskog AB, Engedal K, Coutinho ES, Deslandes AC, Laks J (2014)
    Impaired cognition in depression and Alzheimer (AD): a gradient from depression to depression in AD
    Arq Neuropsiquiatr, 72 (9), 671-9
    DOI 10.1590/0004-282x20140108, PubMed 25252230
  87. Knapskog AB, Barca ML, Engedal K (2013)
    Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia
    Aging Ment Health, 18 (5), 579-87
    DOI 10.1080/13607863.2013.827630, PubMed 23998196
  88. Knapskog AB, Barca ML, Engedal K (2013)
    A comparison of the cornell scale for depression in dementia and the Montgomery-Aasberg depression rating scale in a memory clinic population
    Dement Geriatr Cogn Disord, 35 (5-6), 256-65
    DOI 10.1159/000348345, PubMed 23594823
  89. Knapskog AB, Portugal Mda G, Barca ML, Coutinho ES, Laks J, Engedal K (2012)
    A cross-cultural comparison of the phenotype of depression as measured by the Cornell Scale and the MADRS in two elderly outpatient populations
    J Affect Disord, 144 (1-2), 34-41
    DOI 10.1016/j.jad.2012.06.003, PubMed 22858259
  90. Knapskog AB, Barca ML, Engedal K (2011)
    A comparison of the validity of the Cornell Scale and the MADRS in detecting depression among memory clinic patients
    Dement Geriatr Cogn Disord, 32 (4), 287-94
    DOI 10.1159/000334983, PubMed 22262043
  91. Portugal Mda G, Coutinho ES, Almeida C, Barca ML, Knapskog AB, Engedal K, Laks J (2011)
    Validation of Montgomery-Åsberg Rating Scale and Cornell Scale for Depression in Dementia in Brazilian elderly patients
    Int Psychogeriatr, 24 (8), 1291-8
    DOI 10.1017/S1041610211002250, PubMed 22185723

 
Scroll to top